Clinical Trials Browser

Phase 2 × BID protein, human × Gastrointestinal × Clear all

NCT05216237 2022-04-11

A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT01243346 2018-06-28

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors